ACKR3 and cancer: So far, one radiolabeled highly selective antibody (ACKR3-mAb) has been tested for in vivo assessment of CXCR7 in mice xenografted with human cancer cells showing correlation of tracer uptake with CXCR7 immunoreactivity (57).